Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient
Eshagh D, Benali K, Dossier A, Chauveheid MP, Rouzaud D, Goulenok T, Papo T, Sacre K
Infection · 2020-06
Abstract
In non-human immunodeficiency virus (HIV)-infected patients, tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) is unusual. The management of corticosteroids-refractory IRIS is unclear. We report on infliximab efficacy for treatment of corticosteroid-resistant TB-IRIS occurring in an immunocompetent patient.
MeSH terms
- Humans
- Tuberculosis
- Adrenal Cortex Hormones
- Antitubercular Agents
- Drug Resistance, Bacterial
- Immunocompromised Host
- Middle Aged
- France
- Female
- Immune Reconstitution Inflammatory Syndrome
- Infliximab